Durham’s Chimerix gets FDA nod to test cancer drug in COVID-19 patients
Date Published:
DURHAM — Chimerix has gotten the green light to test an investigational cancer drug to treat COVID-19 patients.
The Durham-based…
Life Sciences
LabCorp COVID-19 antibody tests available nationwide with no upfront costs
Date Published:
BURLINGTON — Life science conglomerate LabCorp is now offering antibody tests for the virus that causes COVID-19 starting today.
The…
Gene therapy firm AskBio acquires French company targeting deadly brain disease
Date Published:
RESEARCH TRIANGLE PARK – Asklepios BioPharmaceutical (AskBio), a clinical stage gene therapy company in Research Triangle Park, has acquired BrainVectis,…
Raleigh pharma to have second drug tested for potential COVID-19 treatment
Date Published:
With fresh data from existing trials treating COVID-19 patients in Italy and Israel, a Triangle drugmaker has announced a deal…
RedHill Biopharma, which has US HQ in Raleigh, pursues second COVID-19 treatment
Date Published:
RALEIGH – RedHill Biopharma is another step closer to getting one of its potential treatments for COVID-19 tested.
The Israeli…
LabCorp receives FDA approval to sell at-home COVID-19 test
Date Published:
BURLINGTON – Health services giant LabCorp will begin selling an at-home test for the COVID-19 virus after receiving emergency authorization…
Why a JoCo facility could soon be mass producing a COVID-19 treatment
Date Published:
While the world battles the COVID-19 pandemic, a drugmaker with a massive presence in North Carolina is looking for recovered…
RTP nutrition startup lands $5M in funding; Hatteras, Launch Place among backers
Date Published:
RESEARCH TRIANGLE PARK – Panaceutics Nutrition, a provider of personalized nutrition products with operations in Research Triangle Park, has closed…
UNC scientists unravel some of schizophrenia’s secrets through genome sequencing
Date Published:
CHAPEL HILL – Most research about the genetics of schizophrenia has sought to understand the role that genes play in…